LOG IN
SIGN UP
MARKET
LNTH
LNTH
Lantheus Holding
NASDAQ
53.87
-1.61
-2.90%
Opening 12:33 12/07 EST
OPEN
55.74
PREV CLOSE
55.48
HIGH
56.16
LOW
53.66
VOLUME
922.50K
TURNOVER
34.84M
52 WEEK HIGH
87.47
52 WEEK LOW
23.51
MARKET CAP
3.71B
P/E (TTM)
36.18
1D
5D
1M
3M
1Y
5Y
Is RxSight (RXST) Stock Outpacing Its Medical Peers This Year?
Here is how RxSight, Inc. (RXST) and Lantheus Holdings (LNTH) have performed compared to their sector so far this year.
Zacks · 1d ago
Lantheus Holdings Prices $500 Million Convertible Senior Notes Offering
Lantheus Holdings Prices $500 Million Convertible Senior Notes Offering
MT Newswires · 1d ago
Why Iovance Biotherapeutics Shares Are Trading Higher By Around 19%? Here Are 43 Stocks Moving In Monday's Mid-Day Session
Benzinga · 1d ago
VF Corp, Verve Therapeutics And Some Other Big Stocks Moving Lower On Monday
Benzinga · 2d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 2d ago
BRIEF-Lantheus Holdings Announces Proposed Offering Of $500 Million Convertible Senior Notes Due 2027
Reuters · 2d ago
Lantheus Holdings Plans to Offer $500 Million of Convertible Notes
Lantheus Holdings Plans to Offer $500 Million of Convertible Notes
MT Newswires · 2d ago
With My Lantheus Trade, 'If It Ain't Broke, Don't Fix It'
In mid-June we teed up a covered call trade idea on Lantheus Holdings, Inc. . The shares now trade almost exactly to where they were then, which means that trade provided a just over 20% return, even as the equity has traded completely sideways since the...
TheStreet.com · 3d ago
About LNTH
Lantheus Holdings, Inc. is an integrated provider of imaging diagnostics, targeted therapeutics, and artificial intelligence solutions to Find, Fight and Follow serious medical conditions. The Company classify its commercial products in three categories: precision diagnostics, radiopharmaceutical oncology, and strategic partnerships and other revenue. Its products in its precision diagnostics category includes DEFINITY, TechneLite, NEUROLITE, Xenon-133, Cardiolite, Gallium-67 and Thallium-201. Its products in its radiopharmaceutical oncology category includes PYLARIFY and AZEDRA. Its products in its strategic partnerships and other revenue product category includes RELISTOR, Automated Bone Scan Index (aBSI) and PYLARIFY AI. In addition to its commercial products and strategic partnerships with third parties, it also has ongoing clinical development programs, such as 1095 and LMI 1195. Its products are sold in both the United States and internationally.
Webull offers kinds of Lantheus Holdings Inc stock information, including NASDAQ:LNTH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LNTH stock news, and many more online research tools to help you make informed decisions.
You can practice and explore trading LNTH stock methods without spending real money on the virtual paper trading platform.